CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 5,644 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,364 shares (to pay taxes)
- 4/A Grant or award Chief Financial Officer acquired 0 shares (grant or award)
- 4/A Grant or award President and CEO acquired 0 shares (grant or award)
- 4 Open-market buy Director bought 10,000 shares at $7.47 ($74,659)
- 4 Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
Page 31 of 42 · 835 filings